Abbott Collaborates With U.S. Military On Head Injury Diagnostic
This article was originally published in The Gray Sheet
Executive Summary
The U.S Department of Defense announced a collaboration Abbott to develop portable blood tests to help evaluate potential concussions that will run on for Abbott's i-STAT point-of-care testing system.
You may also be interested in...
Abbott Gains FDA Clearance For Lab-Based Concussion Test
Abbott said it received the US FDA nod to run its blood-based test to assess patients for concussions on its Alinity i laboratory instrument. This will make the test more widely available in hospitals and laboratories in the US.
Heightened Concussion Awareness Calls For New Detection Tools
Medical device start-ups are surging into new territory in mild traumatic brain injury or concussion detection, which has heretofore lacked objective diagnostics and monitoring tools. Profiles of Cerora, MC10, Oculogica, and Sway Medical.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”